Special Purpose Technology Platforms

As the need arises for specialty molecules to treat chronic diseases, and as new technologies become available to produce natural, synthetic and bio-synthetic APIs with better results, Noramco will adopt special purpose technology platforms.

These include, but are not limited to platforms pertaining to:

– Production of cannabinoid-based APIs

– Custom synthesis products

– APIs produced by bio-catalysis

– Controlled substance building blocks and intermediates